We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.59%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$13.4B
AUM Growth
–
Cap. Flow
+$13.5B
Cap. Flow
% of AUM
100.99%
Top 10 Holdings %
Top 10 Hldgs %
20.99%
Holding
808
New
808
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$519M |
| 2 |
Philip Morris
PM
|
+$473M |
| 3 |
AstraZeneca
AZN
|
+$314M |
| 4 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$272M |
| 5 |
Corning
GLW
|
+$256M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.79% |
| 2 | Technology | 21.35% |
| 3 | Financials | 10.82% |
| 4 | Consumer Staples | 9.85% |
| 5 | Communication Services | 9.2% |
Similar funds
VGA
Arrowstreet Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Arrowstreet Capital, which disclosed 808 positions worth $13.4B. Its ten largest holdings account for 21% of the portfolio.
Its largest position is GSK: 8,173,369 shares worth $511M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Financials.
- Arrowstreet Capital's largest Q2 2013 buy was GSK: 8,173,369 shares worth $511M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $13.4B portfolio in Q2 2013.
- Arrowstreet Capital disclosed 808 positions in Q2 2013, its first 13F filing on record.
Based on Arrowstreet Capital's 13F filing for Q2 2013, filed 9 Aug 2013.